EVOTEC OAI Signs Two Chemistry Services Contracts With Lilly
EVOTEC OAI, Hamburg, Germany (EVOTEC BioSystems AG, Neuer Markt: EVT), a supplier of integrated high-value added biological, chemical and screening services to the pharmaceutical and biotech industries, has secured two contracts with Eli Lilly and Company (NYSE: LLY), a world leading pharmaceutical company. The two contracts span the provision of chemistry services by EVOTEC OAI to Lilly across drug discovery for the first and process research and development for the second. Each contract covers an initial fixed term of one year with an option to extend. The details of each contract are outlined below:
Discovery Services Agreement Within this Discovery Services Agreement, EVOTEC OAI will provide a team of dedicated Full Time Equivalent (FTE) chemists to work exclusively on the design and synthesis of compounds for lead generation, validation as well as lead optimisation for key drug candidates to be included in Lilly’s discovery pipeline.
Development Services Agreement The Development Services Agreement has a second team of FTE chemists dedicated exclusively to Lilly process research and development projects. The Agreement also calls for EVOTEC OAI to subsequently scale up in its cGMP facilities several of Lilly’s active pharmaceutical ingredients (APIs) for use in clinical trials.
In total, 18 FTEs are contracted to Lilly in these two agreements.
Edwin Moses, EVOTEC OAI’s President and Head of Business Development: "We are delighted to have secured these two contract wins with Lilly, one of the world’s leading pharmaceutical companies. We are pleased to have the opportunity to work with both the European and US arms of their R&D business to help them add value to their drug discovery and development programs through the application of our leading-edge chemistry solutions."
Other news from the department business & finance
These products might interest you

Good Weighing Practice by Mettler-Toledo
Your Concrete Weighing Quality Assurance Plan
GWP Verification service

Milli-Q® Services / MyMilli-Q™ by Merck
Services & Support for Water Purification Systems
Quality Care, Delivered. In Person & Online

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.